MA26621A1 - Composition pour aerosols pharmaceutiques - Google Patents
Composition pour aerosols pharmaceutiquesInfo
- Publication number
- MA26621A1 MA26621A1 MA25536A MA25536A MA26621A1 MA 26621 A1 MA26621 A1 MA 26621A1 MA 25536 A MA25536 A MA 25536A MA 25536 A MA25536 A MA 25536A MA 26621 A1 MA26621 A1 MA 26621A1
- Authority
- MA
- Morocco
- Prior art keywords
- composition
- pharmaceutical aerosols
- aerosols
- pharmaceutical
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- 239000008249 pharmaceutical aerosol Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Biophysics (AREA)
- Otolaryngology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9808152.4A GB9808152D0 (en) | 1998-04-18 | 1998-04-18 | Pharmaceutical aerosol formulation |
GBGB9814709.3A GB9814709D0 (en) | 1998-07-08 | 1998-07-08 | Pharmaceutical aerosol formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
MA26621A1 true MA26621A1 (fr) | 2004-12-20 |
Family
ID=26313483
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA25536A MA26621A1 (fr) | 1998-04-18 | 1999-04-15 | Composition pour aerosols pharmaceutiques |
Country Status (30)
Country | Link |
---|---|
US (1) | US7521042B2 (fr) |
EP (1) | EP1073417B1 (fr) |
JP (1) | JP2002512183A (fr) |
KR (1) | KR20010042816A (fr) |
CN (1) | CN1145478C (fr) |
AP (1) | AP2000001961A0 (fr) |
AR (1) | AR018183A1 (fr) |
AT (1) | ATE228823T1 (fr) |
AU (1) | AU755066B2 (fr) |
BR (1) | BR9909736A (fr) |
CA (1) | CA2328882A1 (fr) |
CO (1) | CO5021210A1 (fr) |
DE (1) | DE69904312T2 (fr) |
DK (1) | DK1073417T3 (fr) |
EA (1) | EA200000956A1 (fr) |
EE (1) | EE200000608A (fr) |
ES (1) | ES2189410T3 (fr) |
HR (1) | HRP20000689A2 (fr) |
HU (1) | HUP0101608A2 (fr) |
ID (1) | ID27887A (fr) |
IL (1) | IL139087A0 (fr) |
IS (1) | IS5665A (fr) |
MA (1) | MA26621A1 (fr) |
NO (1) | NO20005218L (fr) |
NZ (1) | NZ507619A (fr) |
PE (1) | PE20000433A1 (fr) |
PL (1) | PL343491A1 (fr) |
PT (1) | PT1073417E (fr) |
TR (1) | TR200100144T2 (fr) |
WO (1) | WO1999053901A1 (fr) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9616237D0 (en) | 1996-08-01 | 1996-09-11 | Norton Healthcare Ltd | Aerosol formulations |
US6119853A (en) * | 1998-12-18 | 2000-09-19 | Glaxo Wellcome Inc. | Method and package for storing a pressurized container containing a drug |
US6390291B1 (en) * | 1998-12-18 | 2002-05-21 | Smithkline Beecham Corporation | Method and package for storing a pressurized container containing a drug |
DE60001492T2 (de) | 1999-04-14 | 2003-12-18 | Glaxo Group Ltd., Greenford | Pharmazeutische aerosolformulierung |
DK2283817T3 (en) | 2000-11-30 | 2016-09-05 | Vectura Ltd | Process for preparing particles for use in a pharmaceutical composition |
CA2429665C (fr) † | 2000-11-30 | 2013-10-22 | Vectura Limited | Procede de preparation de particules destinees a etre utilisees dans une composition pharmaceutique |
KR20100107083A (ko) * | 2002-12-17 | 2010-10-04 | 메디뮨 엘엘씨 | 생물활성 물질의 고압 분무 건조 |
ITMI20022674A1 (it) * | 2002-12-18 | 2004-06-19 | Chiesi Farma Spa | Procedimento per la preparazione di formulazioni sterili a base di principi attivi farmaceutici cristallini micronizzati da somministrare come sospensioni acquose per inalazione. |
US6962006B2 (en) * | 2002-12-19 | 2005-11-08 | Acusphere, Inc. | Methods and apparatus for making particles using spray dryer and in-line jet mill |
US20040121003A1 (en) * | 2002-12-19 | 2004-06-24 | Acusphere, Inc. | Methods for making pharmaceutical formulations comprising deagglomerated microparticles |
PE20040950A1 (es) | 2003-02-14 | 2005-01-01 | Theravance Inc | DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS |
JP2006528985A (ja) * | 2003-05-19 | 2006-12-28 | バクスター・インターナショナル・インコーポレイテッド | 1つ以上の界面改変剤でコーティングされた、抗癲癇剤または免疫抑制剤を含有する固体粒子 |
TWI341836B (en) | 2004-03-11 | 2011-05-11 | Theravance Inc | Biphenyl compounds useful as muscarinic receptor antagonists |
US7569586B2 (en) | 2004-08-16 | 2009-08-04 | Theravance, Inc. | Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
WO2006086270A1 (fr) * | 2005-02-10 | 2006-08-17 | Glaxo Group Limited | Procedes de fabrication du lactose au moyen de techniques de pre-classification et preparations pharmaceutiques ainsi obtenues |
IN2014MN00380A (fr) | 2006-06-30 | 2015-06-19 | Iceutica Pty Ltd | |
US9737640B2 (en) | 2006-11-20 | 2017-08-22 | Lutonix, Inc. | Drug releasing coatings for medical devices |
US8414910B2 (en) | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Drug releasing coatings for medical devices |
US20080276935A1 (en) | 2006-11-20 | 2008-11-13 | Lixiao Wang | Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs |
US8414525B2 (en) | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Drug releasing coatings for medical devices |
US9700704B2 (en) | 2006-11-20 | 2017-07-11 | Lutonix, Inc. | Drug releasing coatings for balloon catheters |
US8425459B2 (en) | 2006-11-20 | 2013-04-23 | Lutonix, Inc. | Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent |
US8414909B2 (en) | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Drug releasing coatings for medical devices |
US8998846B2 (en) | 2006-11-20 | 2015-04-07 | Lutonix, Inc. | Drug releasing coatings for balloon catheters |
US8414526B2 (en) | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids |
US8430055B2 (en) | 2008-08-29 | 2013-04-30 | Lutonix, Inc. | Methods and apparatuses for coating balloon catheters |
US8236862B2 (en) | 2009-02-06 | 2012-08-07 | University Of Southern California | Therapeutic compositions comprising monoterpenes |
EP4403231A2 (fr) | 2009-02-26 | 2024-07-24 | Glaxo Group Limited | Préparations pharmaceutiques comprenant 4-{(1r)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]éthoxy}hexyl)amino]-1-hydroxyéthyl}-2-(hydroxyméthyl)-phénol |
JP5651174B2 (ja) | 2009-07-15 | 2015-01-07 | セラヴァンス バイオファーマ アール&ディー アイピー, エルエルシー | ビフェニル化合物の結晶性遊離塩基形 |
GB0921075D0 (en) | 2009-12-01 | 2010-01-13 | Glaxo Group Ltd | Novel combination of the therapeutic agents |
US8507734B2 (en) | 2010-03-03 | 2013-08-13 | Neonc Technologies Inc. | Pharmaceutical compositions comprising monoterpenes |
EP2570120B1 (fr) * | 2010-06-08 | 2017-10-25 | Kobe Gakuin Educational Foundation | Particule enrobée et procédé pour la production de particule enrobée |
ES2600928T3 (es) | 2010-08-27 | 2017-02-13 | Neonc Technologies Inc. | Composiciones farmacéuticas que comprenden derivados de alcohol perilílico |
WO2012083178A1 (fr) | 2010-12-17 | 2012-06-21 | Neo Oncology Inc. | Procédés et dispositifs pour l'utilisation d'alcool isoperillylique |
US20160038600A1 (en) | 2012-08-03 | 2016-02-11 | Neonc Technologies Inc. | Pharmaceutical compositions comprising poh derivatives |
CN102366405A (zh) * | 2011-10-21 | 2012-03-07 | 江阴长风医药科技有限公司 | 以氢氟烷烃为抛射剂的氟替卡松丙酸酯气雾剂制剂 |
JP6231022B2 (ja) | 2012-02-28 | 2017-11-15 | アイシューティカ ホールディングス インク.Iceutica Holdings Inc. | 吸入可能な医薬組成物 |
RS57075B1 (sr) | 2013-03-15 | 2018-06-29 | Verona Pharma Plc | Kombinacija leka |
RU2688191C2 (ru) | 2014-05-12 | 2019-05-21 | ВЕРОНА ФАРМА ПиэЛСи | Новое лечение |
EP3872069A1 (fr) | 2015-02-12 | 2021-09-01 | Neonc Technologies, Inc. | Compositions pharmaceutiques comprenant des dérivés d'alcool périllylique |
CN106546751A (zh) * | 2016-11-16 | 2017-03-29 | 广州华弘生物科技有限公司 | 用于检测oct4蛋白的酶联免疫试剂盒 |
WO2018102412A1 (fr) | 2016-11-30 | 2018-06-07 | Neonc Technologies, Inc. | Conjugué d'alcool périllylique-3-bromopyruvate et méthodes de traitement de cancer |
US20210228498A1 (en) | 2018-02-08 | 2021-07-29 | Neonc Technologies, Inc. | Methods of permeabilizing the blood brain barrier |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5141674A (en) * | 1984-03-08 | 1992-08-25 | Phares Pharmaceutical Research N.V. | Methods of preparing pro-liposome dispersions and aerosols |
ES2053549T3 (es) * | 1986-08-11 | 1994-08-01 | Innovata Biomed Ltd | Un proceso para la preparacion de una formulacion farmaceutica apropiada para inhalacion. |
GB9024365D0 (en) * | 1990-11-09 | 1991-01-02 | Glaxo Group Ltd | Medicaments |
EP0655237A1 (fr) * | 1993-11-27 | 1995-05-31 | Hoechst Aktiengesellschaft | Composition d'aerosol medicinal |
GB9426252D0 (en) * | 1994-12-24 | 1995-02-22 | Glaxo Group Ltd | Pharmaceutical composition |
US5876760A (en) * | 1995-06-12 | 1999-03-02 | Ono Pharmaceutical Co., Ltd. | Granules containing pranlukast, process for producing the granules, and method of improving adhesiveness of pranlukast |
GB9606677D0 (en) * | 1996-03-29 | 1996-06-05 | Glaxo Wellcome Inc | Process and device |
EP0952821A4 (fr) * | 1996-12-31 | 2006-07-26 | Nektar Therapeutics | Procedes permettant de secher par pulverisation de suspensions aqueuses de medicaments hydrophobes avec des excipients hydrophiles et compositions preparees selon ces procedes |
-
1999
- 1999-04-15 AU AU35231/99A patent/AU755066B2/en not_active Ceased
- 1999-04-15 IL IL13908799A patent/IL139087A0/xx unknown
- 1999-04-15 WO PCT/EP1999/002535 patent/WO1999053901A1/fr not_active Application Discontinuation
- 1999-04-15 DK DK99916921T patent/DK1073417T3/da active
- 1999-04-15 TR TR2001/00144T patent/TR200100144T2/xx unknown
- 1999-04-15 CA CA002328882A patent/CA2328882A1/fr not_active Abandoned
- 1999-04-15 EE EEP200000608A patent/EE200000608A/xx unknown
- 1999-04-15 PT PT99916921T patent/PT1073417E/pt unknown
- 1999-04-15 EP EP99916921A patent/EP1073417B1/fr not_active Expired - Lifetime
- 1999-04-15 PL PL99343491A patent/PL343491A1/xx unknown
- 1999-04-15 CO CO99022532A patent/CO5021210A1/es unknown
- 1999-04-15 ID IDW20002392A patent/ID27887A/id unknown
- 1999-04-15 ES ES99916921T patent/ES2189410T3/es not_active Expired - Lifetime
- 1999-04-15 EA EA200000956A patent/EA200000956A1/ru unknown
- 1999-04-15 JP JP2000544308A patent/JP2002512183A/ja not_active Ceased
- 1999-04-15 HU HU0101608A patent/HUP0101608A2/hu unknown
- 1999-04-15 KR KR1020007011572A patent/KR20010042816A/ko not_active Application Discontinuation
- 1999-04-15 NZ NZ507619A patent/NZ507619A/en unknown
- 1999-04-15 AP APAP/P/2000/001961A patent/AP2000001961A0/en unknown
- 1999-04-15 DE DE69904312T patent/DE69904312T2/de not_active Expired - Fee Related
- 1999-04-15 MA MA25536A patent/MA26621A1/fr unknown
- 1999-04-15 CN CNB998072818A patent/CN1145478C/zh not_active Expired - Fee Related
- 1999-04-15 BR BR9909736-2A patent/BR9909736A/pt not_active Application Discontinuation
- 1999-04-15 AT AT99916921T patent/ATE228823T1/de not_active IP Right Cessation
- 1999-04-15 AR ARP990101747A patent/AR018183A1/es unknown
- 1999-04-16 PE PE1999000318A patent/PE20000433A1/es not_active Application Discontinuation
-
2000
- 2000-10-13 IS IS5665A patent/IS5665A/is unknown
- 2000-10-17 NO NO20005218A patent/NO20005218L/no not_active Application Discontinuation
- 2000-10-18 HR HR20000689A patent/HRP20000689A2/hr not_active Application Discontinuation
-
2003
- 2003-02-11 US US10/364,257 patent/US7521042B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA26621A1 (fr) | Composition pour aerosols pharmaceutiques | |
ID22891A (id) | Komposisi farmasi untuk kombinasi piperidinoalkanol-dekongestan | |
ID27415A (id) | Komposisi farmaseutik | |
FR2775596B1 (fr) | Nouvelles compositions pharmaceutiques | |
FI973518A (fi) | Farmaseuttinen koostumus piperidinoalkanoliyhdisteille | |
DK1052974T3 (da) | Farmaceutisk sammensætning indeholdende epothilon | |
IS5046A (is) | Lyfjasamsetningar | |
NO20015175D0 (no) | Farmasöytisk sammensetning | |
NO20005913D0 (no) | Legemiddelsammensetning | |
DK0920302T4 (da) | Farmaceutisk aerosolsammensætning | |
ID29262A (id) | Komposisi farmasi | |
ID27201A (id) | Komposisi farmasi | |
ID27150A (id) | Sediaan levotiroksin bahan farmasi | |
ID29294A (id) | Komposisi farmasi | |
BR9507768A (pt) | Composição farmacêutica | |
PT1227817E (pt) | Composicao farmaceutica aquosa contendo ciclesonida | |
ID25857A (id) | Komposisi farmasi | |
FI4488U1 (fi) | Farmaseuttinen koostumus | |
ID18698A (id) | Komposisi farmasi | |
FR2779145B1 (fr) | Nouvelles compositions pharmaceutiques | |
EE200100281A (et) | Analgeetiline ravimkoostis | |
ID26215A (id) | Komposisi farmasi | |
ITMI962628A0 (it) | Composizione farmaceutica | |
ID23531A (id) | Komposisi farmasi | |
UA2861S (uk) | Форма для виливання супозиторіїв |